Publicaciones (63) Publicaciones de ISAAC ANTOLIN GONZALEZ

2024

  1. Endoplasmic reticulum regulation of glucose metabolism in glioma stem cells

    International journal of oncology, Vol. 64, Núm. 1

2021

  1. Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration

    Journal of Cellular Physiology, Vol. 236, Núm. 1, pp. 27-40

2020

  1. Role of glucose metabolism in the differential antileukemic effect of melatonin on wild-type and FLT3-ITD mutant cells

    Oncology Reports, Vol. 44, Núm. 1, pp. 293-302

2018

  1. Inhibition of flt3 and pim kinases by ec-70124 exerts potent activity in preclinical models of acute myeloid leukemia

    Molecular Cancer Therapeutics, Vol. 17, Núm. 3, pp. 614-624

2016

  1. Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin

    Molecular and Cellular Endocrinology, Vol. 434, pp. 238-249

2015

  1. Melatonin cytotoxicity is associated to Warburg effect inhibition in Ewing sarcoma cells

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells

    Journal of Pineal Research, Vol. 57, Núm. 3, pp. 308-316

2013

  1. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells

    International Journal of Molecular Sciences, Vol. 14, Núm. 4, pp. 6597-6613

  2. Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells

    British Journal of Cancer, Vol. 108, Núm. 10, pp. 2005-2012

2012

  1. Cooperative action of JNK and AKT/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells

    Journal of Neuroscience Research, Vol. 90, Núm. 9, pp. 1850-1860

  2. Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

    British Journal of Cancer, Vol. 106, Núm. 7, pp. 1288-1296

2011

  1. Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells

    Free Radical Research, Vol. 45, Núm. 11-12, pp. 1333-1341

  2. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients

    Journal of Pineal Research, Vol. 50, Núm. 3, pp. 345-355

2010

  1. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death

    Cancer Letters, Vol. 287, Núm. 2, pp. 216-223

  2. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: Potentiation of the extrinsic apoptotic pathway

    Journal of Pineal Research, Vol. 48, Núm. 1, pp. 72-80

2008

  1. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine

    Journal of Neurochemistry, Vol. 107, Núm. 1, pp. 127-140

2007

  1. Antioxidants do not prevent acrylonitrile-induced toxicity

    Toxicology Letters, Vol. 169, Núm. 3, pp. 236-244

  2. Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells

    Journal of Pineal Research, Vol. 43, Núm. 3, pp. 239-244

  3. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria

    Journal of Neurochemistry, Vol. 100, Núm. 3, pp. 736-746

  4. Signaling pathways involved in antioxidant control of glioma cell proliferation

    Free Radical Biology and Medicine, Vol. 42, Núm. 11, pp. 1715-1722